MeiraGTx Announces $400 million Strategic Investment by Oberland Capital to Support Development and Commercialization of AAV2-hAQP1 and Botaretigene Sparoparvovec (bota-vec)

Go back to MeiraGTx Announces $400 million Strategic Investment by Oberland Capital to Support Development and Commercialization of AAV2-hAQP1 and Botaretigene Sparoparvovec (bota-vec)
(NASDAQ: MGTX) Delayed: 13.26 -0.27 (2%)
Previous Close $13.53    52 Week High
Open $13.40    52 Week Low
Day High $13.76    P/E N/A 
Day Low $13.25    EPS
Volume 534,315       

(NASDAQ: MGTX) Delayed: 13.26 -0.27 (2%)
Previous Close $13.53    52 Week High
Open $13.40    52 Week Low
Day High $13.76    P/E N/A 
Day Low $13.25    EPS
Volume 534,315